These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 884683)

  • 41. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
    Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
    Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
    Kaminski MS; Kitamura K; Maloney DG; Levy R
    J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
    Hines DL
    Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
    Hostetler LW; Romerdahl CA; Kripke ML
    Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.
    Arnold LW; LoCascio NJ; Lutz PM; Pennell CA; Klapper D; Haughton G
    J Immunol; 1983 Oct; 131(4):2064-8. PubMed ID: 6194226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition.
    Bakouche O; Gerlier D
    Immunology; 1986 Jul; 58(3):507-13. PubMed ID: 3733150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
    Mizushima Y; Sendo F; Miyake T; Kobayashi H
    J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors.
    Glaser M; Kirchner H; Herberman RB
    Int J Cancer; 1975 Sep; 16(3):384-93. PubMed ID: 1176200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergy in proliferative and cytotoxic responses of WF rats to syngeneic Gross virus-induced lymphoma cells in vitro.
    Wright PW; Loop SM; Bernstein ID
    J Natl Cancer Inst; 1980 Feb; 64(2):303-8. PubMed ID: 6965510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transplantability, immunological unresponsiveness, and loss of cellular antigenicity in gross virus lymphoma.
    Ioachim HL; Keller SE; Dorsett BH
    Bibl Haematol; 1975; (40):301-10. PubMed ID: 51627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gross-virus-induced lymphoma in the rat. IV. Cytotoxic cells in normal rats.
    Shellam GR; Hogg N
    Int J Cancer; 1977 Feb; 19(2):212-24. PubMed ID: 838521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody-dependent cellular cytotoxicity to a syngeneic Gross virus-induced lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Natl Cancer Inst; 1974 Jan; 52(1):147-52. PubMed ID: 4204244
    [No Abstract]   [Full Text] [Related]  

  • 56. Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma.
    Ioachim HL; Keller SE; Dorsett BH; Pearse A
    J Exp Med; 1974 Jun; 139(6):1382-94. PubMed ID: 4208416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of immune complexes in serum by adsorption on staphylococcal protein A: model studies and application to sera of rats bearing a gross virus-induced lymphoma.
    Tucker DF; Begent RH; Hogg NM
    J Immunol; 1978 Nov; 121(5):1644-51. PubMed ID: 712061
    [No Abstract]   [Full Text] [Related]  

  • 58. Immune response to Gross virus-induced lymphoma: comparison of two in vitro assays of cell-mediated immunity.
    Wright PW; Ortiz de Landazuri M; Herberman RB
    J Natl Cancer Inst; 1973 Apr; 50(4):947-54. PubMed ID: 4574190
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunogenicity of tumor antigens.
    Herberman RB; Campbell DA; Oldham RK; Bonnard GD; Ting CC; Holden HT; Glaser M; Djeu J; Oehler R
    Ann N Y Acad Sci; 1976; 276():26-44. PubMed ID: 194517
    [No Abstract]   [Full Text] [Related]  

  • 60. Antigenic inhibition of cell-mediated cytotoxicity against tumour cells.
    Shellam GR; Knight RA
    Nature; 1974 Nov; 252(5481):330-2. PubMed ID: 4372543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.